Sands Capital
About Sands Capital
Sands Capital is an active, long-term investor in leading innovative growth businesses, globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future.
Recent News
The Social Economy Is Worth Trillions. Chronicle Is Building the Agentic Infrastructure to Unlock It.
Elephas Biosciences Receives $40M Series B-2
PolyAI Secures $86M Series D Funding
Codoxo Lands Oversubscribed Series C Funding
Impulse Dynamics Completes $158M Financing Round
Keebler Health Raises $16M for AI Risk Adjustment Platform
Recent Deals
PolyAI Secures $86M Series D Funding
Codoxo Secures $35M Series C to Accelerate AI‑Powered Healthcare Payments
Impulse Dynamics Secures Over $158M in Growth Funding
Elephas Biosciences Secures $40M Series B-2 Funding to Advance Live Tumor Profiling Platform
Keebler Health Secures $16M Series A Funding Led by Flare Capital Partners
Chronicle Raises $12M in Funding Round Backed by Patron, Point72 Ventures, Z Ventures and Sands Capital
Codoxo Secures $35M Series C Funding Led by CVS Health Ventures
Impulse Dynamics Secures $158M Funding Round to Accelerate HF Therapy Commercialization
Cnuic Raises $3M Pre‑seed Round Led by Tensor Ventures
RevEng.AI Raises $15M Series A Led by NATO Innovation Fund
Sands Capital Raises $1.1bn for Third Global Innovation Fund